STAT
March 18, 2024
Honora Englander, M.D., is quoted in the final segment of STAT News’ four-part series highlighting resistance in the U.S. to addiction medication such as methadone, despite the fact that barely a fifth of Americans with opioid use disorder receive treatment and tens of thousands are dying annually. Citing the contrast in France, where she’s studying under a Fulbright scholarship, Englander says, “There are stunning differences in terms of treatment access, and there are stunning differences in terms of overdose rates. … The work of being a patient in France is far less. Instead of traveling daily to [a methadone clinic], patients can — even relatively early in treatment — get several weeks of methadone at a time from their local community pharmacy. The bar to access treatment is so much lower, and it’s not chaos. People are getting really good care.”